Siemens Healthineers (OTCMKTS:SMMNY) Announces Earnings Results, Beats Expectations By $0.03 EPS

Siemens Healthineers (OTCMKTS:SMMNY) posted its earnings results on Thursday. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03, reports. The business had revenue of $6.37 billion during the quarter, compared to the consensus estimate of $5.29 billion.

Siemens Healthineers Trading Up 0.5%

SMMNY stock opened at $24.93 on Friday. The company has a fifty day moving average price of $25.90 and a 200 day moving average price of $26.67. Siemens Healthineers has a 12 month low of $23.28 and a 12 month high of $30.19.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on SMMNY shares. Sanford C. Bernstein raised shares of Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Citigroup reaffirmed a “buy” rating on shares of Siemens Healthineers in a research note on Friday, January 23rd. Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Royal Bank Of Canada initiated coverage on shares of Siemens Healthineers in a report on Wednesday, December 17th. They issued a “moderate buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft lowered Siemens Healthineers from a “buy” rating to a “hold” rating in a report on Thursday, December 4th. Three research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Siemens Healthineers has a consensus rating of “Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.